{"brief_title": "Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)", "brief_summary": "The purpose of this study is to determine the overall survival of patients diagnosed with Stage 3b or 4 non-small cell lung cancer (NSCLC) treated with an oral Farnesyl Protein Transferase Inhibitor (Lonafarnib/SCH 66336) in combination with paclitaxel and carboplatin with that of patients treated with placebo in combination with paclitaxel and carboplatin.", "condition": "Metastases, Neoplasm", "intervention_type": "Drug", "intervention_name": "Lonafarnib (SARASAR)", "criteria": "Inclusion Criteria: - Male or female - Histologically or cytologically 3b or 4 (metastatic) non-small cell lung cancer. Patients must meet any subcriteria as detailed in the protocol. - Age greater than or equal to 18 years old - ECOG performance status of 0 to 1 - Prior diagnosis of brain metastases from NSCLC eligible provided that the brain metastases have been adequately treated, patient is neurologically stable and no new or progressive brain metastases identified. - Meets protocol requirements for specified laboratory values - Written informed consent - Appropriate use of effective contraception if of childbearing potential - Prior basal cell carcinoma or carcinoma in-situ of the cervix are eligible provided they have been treated with no evidence of disease Exclusion Criteria: - Prior chemotherapy for any stage of NSCLC - Prior surgery or radiation therapy within the last 2 weeks or incomplete recovery from prior procedures or therapy - Concurrent treatment or treatment within the last 2 years for any other malignancy - Grade 2 or greater nausea or Grade 1 or greater vomiting (despite antiemetic medication) - Medical conditions that would interfere with taking oral medications - Patients with bone metastases as the only site of disease - Pregnant or nursing women - Known HIV positivity or AIDS-related illness - Patients with significant QTc prolongation at baseline", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00050336.xml"}